Cancer Keys: COVID-19 and Neutropenic Sepsis

3rd April 2020

Neutropenic sepsis is a potentially fatal complication of anticancer treatment (particularly chemotherapy).

Helpful hint:

NICE have produced a COVID-19 rapid guideline on the delivery of systemic anticancer treatments. If patients present with COVID-19 symptoms this guidance recommends:

  • Be aware that patients having systemic anticancer treatments are immunocompromised and may have atypical presentations of COVID‑19. Also, symptoms of COVID‑19, neutropenic sepsis and pneumonitis may be difficult to differentiate at initial presentation.
  • Advise all patients to contact their local cancer chemotherapy helpline (rather than NHS 111) if they feel unwell to ensure their symptoms are appropriately assessed.
  • If patients have fever (with or without respiratory symptoms), suspect neutropenic sepsis because this can be rapid and life-threatening, and follow the NICE guideline on neutropenic sepsis, which recommends referring patients with suspected neutropenic sepsis immediately for assessment in secondary or tertiary care.

Cancer Keys are brought to you by GatewayC.

Download this Cancer Key here

LinkedIn Twitter | Facebook

Latest from the Blog

Prostate cancer: who is most at risk?

Prostate cancer: who is most at risk?

21 July 2022 Prostate cancer accounts for 27% of all new cancer cases in males in the UK, with around 52,300 new diagnoses each year. Black men have a higher risk of prostate cancer Prostate cancer risk is higher in Black males compared with White or Asian males....

read more

Related Posts

Prostate cancer: who is most at risk?

Prostate cancer: who is most at risk?

21 July 2022 Prostate cancer accounts for 27% of all new cancer cases in males in the UK, with around 52,300 new diagnoses each year. Black men have a higher risk of prostate cancer Prostate cancer risk is higher in Black males compared with White or Asian males....

read more